Hims & Hers Shuts Down Acquired Dermatology Business and Skincare Site
In a recent development, telehealth company Hims & Hers has announced that it will be shutting down the dermatology business it acquired in 2021, Apostrophe, and its associated skincare site. The decision comes as part of an effort to centralize the company’s teledermatology offerings.
Background
Hims & Hers, a telehealth startup, has been making waves in the healthcare industry with its digital platform offering various health services, including telemedicine, prescription medications, and wellness products. In 2021, the company expanded its offerings by acquiring Apostrophe, a direct-to-consumer dermatology business focused on personalized skincare and virtual consultations.
Reasons for Shutting Down
According to a spokesperson for Hims & Hers, the decision to shut down Apostrophe and its related skincare site was made to streamline the company’s operations and better focus on its core teledermatology offerings. By centralizing these services, the company aims to provide a more consistent and comprehensive experience for its customers.
Impact on Customers
For customers of Apostrophe, this development may mean some changes to their skincare regimens and virtual consultations. Hims & Hers has stated that they will be working to transition affected customers to their main platform as smoothly as possible. However, some may experience disruptions in their care, particularly if they relied on Apostrophe’s unique offerings or specialized dermatologists.
Impact on the Industry
The closure of Apostrophe and its integration into Hims & Hers’ platform could potentially shift the competitive landscape within the telehealth and dermatology industries. By consolidating their offerings, Hims & Hers may gain an edge in the market, particularly in the increasingly crowded telehealth space. However, it also raises questions about the future of smaller, niche players in the industry and the potential for further consolidation.
Conclusion
Hims & Hers’ decision to shut down Apostrophe and its associated skincare site marks a significant shift in the company’s strategy, as it looks to centralize its teledermatology offerings. While this move may bring about some changes for affected customers and potentially impact the competitive landscape, it also underscores the ongoing trend towards digital health services and the continued evolution of the telehealth industry.
- Hims & Hers acquires Apostrophe in 2021
- Company to shut down Apostrophe and skincare site
- Decision aimed at centralizing teledermatology offerings
- Customers to be transitioned to Hims & Hers platform
- Impact on competitive landscape to be seen
